scholarly article | Q13442814 |
P2093 | author name string | Andreas Stallmach | |
Tony Bruns | |||
Ignacio Rubio | |||
Sven Stengel | |||
Caroline Schmidt | |||
Eihab Al-Herwi | |||
Jack Peter | |||
Martina Mai | |||
P2860 | cites work | An integrated map of genetic variation from 1,092 human genomes | Q22122153 |
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex | Q24295120 | ||
PRR5L degradation promotes mTORC2-mediated PKC-δ phosphorylation and cell migration downstream of Gα12 | Q24323912 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
The International HapMap Project | Q27860695 | ||
Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling | Q28278006 | ||
TRAF6 Is a Critical Factor for Dendritic Cell Maturation and Development | Q28505658 | ||
HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants | Q29614906 | ||
Thrombocytopenia identifies a severe familial phenotype of systemic lupus erythematosus and reveals genetic linkages at 1q22 and 11p13. | Q33344870 | ||
Evaluation of TRAF6 in a large multiancestral lupus cohort | Q33399089 | ||
Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile | Q33656103 | ||
TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. | Q34180844 | ||
The INCA trial (Impact of NOD2 genotype-guided antibiotic prevention on survival in patients with liver Cirrhosis and Ascites): study protocol for a randomized controlled trial. | Q35177083 | ||
Discovery of small molecule CD40-TRAF6 inhibitors | Q35549406 | ||
Genetic variation in the TNF receptor-associated factor 6 gene is associated with susceptibility to sepsis-induced acute lung injury | Q36338552 | ||
Analysis of monocyte chemotactic protein-1 gene polymorphism in patients with spontaneous bacterial peritonitis | Q37445624 | ||
Risk factors and outcome of bacterial infections in cirrhosis | Q37629681 | ||
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis | Q37773059 | ||
Immune dysfunction and infections in patients with cirrhosis | Q37852409 | ||
Spontaneous bacterial peritonitis: recent guidelines and beyond | Q37965448 | ||
Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure | Q39533703 | ||
Nucleotide-Binding Oligomerization Domain-Containing Protein 2 Variants in Patients with Spontaneous Bacterial Peritonitis | Q40847568 | ||
A variant in the nuclear dot protein 52kDa gene increases the risk for spontaneous bacterial peritonitis in patients with alcoholic liver cirrhosis. | Q40940501 | ||
Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains | Q42412022 | ||
Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality | Q43490218 | ||
Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. | Q44105999 | ||
Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors | Q44178776 | ||
High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33. | Q44922542 | ||
Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis | Q45569255 | ||
EASL clinical practice guidelines for HFE hemochromatosis | Q46110938 | ||
NOD2 gene variants are a risk factor for culture-positive spontaneous bacterial peritonitis and monomicrobial bacterascites in cirrhosis. | Q53234198 | ||
Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis | Q56925206 | ||
Further evidence for the relevance of TLR2 gene variants in spontaneous bacterial peritonitis | Q58097238 | ||
Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis | Q82578771 | ||
Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis | Q83486899 | ||
Low ascitic fluid protein does not indicate an increased risk for spontaneous bacterial peritonitis in current cohorts | Q85220793 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | spontaneous bacterial peritonitis | Q3128789 |
P304 | page(s) | 4914 | |
P577 | publication date | 2017-07-07 | |
P1433 | published in | Scientific Reports | Q2261792 |
P1476 | title | Genetic variants of TRAF6 modulate peritoneal immunity and the risk of spontaneous bacterial peritonitis in cirrhosis: A combined prospective-retrospective study | |
P478 | volume | 7 |
Q91782424 | Analysis of Risk Factors for Patients with Liver Cirrhosis Complicated with Spontaneous Bacterial Peritonitis |
Q90066254 | Can Macrophages in Cirrhotic Ascites Fluid Predict Clinical Outcome in Spontaneous Bacterial Peritonitis? |
Q47299173 | Functional polymorphisms of innate immunity receptors are not risk factors for the non-SBP type bacterial infections in cirrhosis. |
Q92745001 | Mucosal-Associated Invariant T Cells Redistribute to the Peritoneal Cavity During Spontaneous Bacterial Peritonitis and Contribute to Peritoneal Inflammation |
Search more.